Navigation Links
Pradaxa Gains Preferred Formulary Status with Key Pharmacy Benefit Managers
Date:3/14/2011

RIDGEFIELD, Conn., March 14, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), today announced that Pradaxa® (dabigatran etexilate mesylate) capsules has received preferred Tier 2 formulary status with CVS Caremark (Commercial Preferred Drug List) and Medco (Commercial Preferred and Part D Drug Lists), two of the largest pharmacy benefit managers covering more than 100 million Americans.(1) The U.S. Food and Drug Administration (FDA) approved PRADAXA in October 2010 to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF).(2)

Five months after FDA approval, PRADAXA is now available at the lowest branded co-pay level on formularies that insure about 35 percent of NVAF patients.(1) For those patients who may not otherwise be able to afford treatment, BIPI offers patient assistance programs to help provide coverage for the costs of their medications.

In the pivotal RE-LY trial, PRADAXA 150mg capsules taken twice daily reduced the incidence of stroke and systemic embolism by 35 percent beyond the reduction achieved with warfarin(2), which was dosed to a target international normalized ratio (INR) of 2.0 to 3.0.(2) The effects of PRADAXA compared to warfarin were more apparent in patients with lower levels of INR control.(2)

"These formulary additions will offer non-valvular atrial fibrillation patients increased access to PRADAXA, including its demonstrated ability to significantly reduce the risk of stroke over warfarin in this patient population," said Wa'el Hashad, vice president, cardiovascular and metabolic disorders marketing, Boehringer Ingelheim Pharmaceuticals, Inc. "We look forward to a long relationship with CVS Caremark and Medco, and are committed to working with other pharmacy benefit managers as well as offering our own programs to help make PRADAXA available to patients with non-valvular atrial fibrillation."

PRADAXA is the only FDA-approved treat
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Sub-Analysis of RE-LY Trial Examines Pradaxa in Patients with Atrial Fibrillation Undergoing Cardioversion
2. New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Associations Scientific Sessions
3. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
4. FDA Approves Pradaxa, Marking a Major Milestone to Reduce the Risk of Stroke in Patients with Non-Valvular Atrial Fibrillation
5. FDA Approves Pradaxa to Prevent Stroke in People With Atrial Fibrillation
6. Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device
7. Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device
8. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
9. OncoMed Anti-Cancer Stem Cell Antibody OMP-21M18 Demonstrates Potent Activity in Preclinical Studies Against Human Colon Cancer Tumors Regardless of KRAS Mutation Status
10. Plexus Biomedical Inc. Gains FDA Approval of the First Medical Device to Help Prevent External Hemorrhoids During Vaginal Childbirth
11. FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 4, 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... Ch.B., Sangamo,s executive vice president, research and development, will ... Therapeutic ® development programs and an overview of ... August 11, 2015, at the 2015 Wedbush Pacgrow Healthcare ... New York, NY . The presentation ...
(Date:8/4/2015)... , Aug. 04, 2015 ... has announced the addition of the "MRI ... Comfort and Operational Efficiency, with Growth Driven by ... "MRI Systems Market to 2020 - Focus ... Driven by Developing Economies" discusses the market, competitive ...
(Date:8/4/2015)... 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... million for the three and six months ended June ... $12.1 million and $43.4 million for the same periods ... primarily by the more than $90 million of revenue ... upfront payment from Bayer to license  ISIS-FXI Rx .  ...
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
... SAN DIEGO, Sept. 7, 2011 ResMed Inc. (NYSE: ... upcoming conferences: Morgan Stanley Global Healthcare Conference at ... UBS Global Life Sciences Conference at the Grand Hyatt ... Suisse 2011 Healthcare Conference at the Arizona Biltmore Hotel in Phoenix, ...
... SAN DIEGO, Sept. 7, 2011 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Stanley Global Healthcare Unplugged Conference on Wednesday, September ... in New York. Daniel M. Bradbury, president and chief executive ... The presentation will be webcast live through the "Investors" section ...
Cached Medicine Technology:ResMed Inc. to Present at Upcoming Conferences 2
(Date:8/4/2015)... ... August 04, 2015 , ... How cool is it to ... you via geolocation? The new "Now" feature will soon allow you to do just ... to inspire each other using the now feature. , Users will soon get to ...
(Date:8/4/2015)... ... August 05, 2015 , ... The Journal of Pain ... ”. , As corresponding author Professor Akiko Okifuji says “Both obesity and chronic pain ... is not to say that one causes the other. Rather, there appear to be ...
(Date:8/4/2015)... ... August 04, 2015 , ... World Patent Marketing, a ... Rack, a fitness invention that eliminates the need to have a partner or ... Clubs industry is worth $30 billion," says Scott Cooper, CEO and Creative Director ...
(Date:8/4/2015)... ... , ... assistPoint Partners, LLC is proud to announce ... programs. Through a secure web portal, assistPoint connects Life Sciences, Patients and Providers ... application and workflow solution. This provides cancer center patient advocates, financial counselors and ...
(Date:8/4/2015)... ... 04, 2015 , ... The United Nations Foundation today announced ... Indonesia for a select group of U.S.-based journalists during the week of November ... the International Conference on Family Planning in Bali. , In close coordination ...
Breaking Medicine News(10 mins):Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:assistPoint.com Web Site Launched 2Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2
... OAKLAND, Calif., Dec. 9 The Kenneth Rainin Foundation announced ... to support education and the arts in the San Francisco ... address the Foundation,s mission to enhance quality of life by ... inspiration through the magic of the arts. The Foundation is ...
... NEWPORT BEACH, Calif., Dec. 9 Hoag Hospital has ... for cardiovascular care by Thomson Reuters. , Thomson ... -- examined the performance of 971 hospitals by analyzing ... heart attacks and for those who received coronary bypass ...
... to six percent of children in the U.S. suffering from ... physicians aren,t always confident they have the ability to diagnose ... in the January 2010 issue of Pediatrics and ... Children,s Memorial Hospital and Assistant Professor of Pediatrics at Northwestern ...
... to limit effects on brain , WEDNESDAY, Dec. 9 ... reduce brain damage caused by Alzheimer,s disease, a new ... in the brain plays a major role in Alzheimer,s, ... the accumulation of A-beta plaques, according to background information ...
... , ... 9 Virtual Health Technologies, Inc. (OTC Bulletin Board: VHGI) and ... Cohen Independent Research Group, Inc., Wall Street,s leading independent fundamental research ... recommendation and a long-term target price of $2.48. , Mr. Cohen ...
... , SCOTTSDALE, Ariz. and BANGKOK, Dec. ... http://www.mtqua.org ), announces the first program to train and certify ... "All medical tourists who want treatment in another country now ... International Patient Advisor (CIPA) and map out the best road ...
Cached Medicine News:Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 2Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 3Health News:Hoag Hospital Named One of the Nation's Top Cardiovascular Hospitals by Thomson Reuters 2Health News:Hoag Hospital Named One of the Nation's Top Cardiovascular Hospitals by Thomson Reuters 3Health News:Physicians knowledge of childhood food allergies needs room for improvement 2Health News:Potential New Target Found for Alzheimer's Disease 2Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 2Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 3Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 4Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 5Health News:Medical Travel Quality Alliance to Certify Medical Tourism Agents for Safer, Quality Health Care for Traveling International Patients 2
Tip is bent towards port for downward irrigation. 25G x 5/8in (.50 x 22mm)...
... product designed for LASIK surgery and other ... the corneal interface and/or stromal bed. Flattened ... and helps elevate the flap edge. Multiple ... G (.40 x 22mm). Angled 90 degrees, ...
... LASIK surgery and other types of ... corneal interface and/or stromal bed. Flattened ... flap and helps elevate the flap ... 23G x 7/8in (.60 x 22mm) ...
... is specially rounded, extra smooth ... and manipulation in the anterior ... tubing 25cm, ID - 1mm ... rings start .85mm from ...
Medicine Products: